We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LOW:NYSELowe's Companies, Inc. Analysis

Data as of 2026-09-09 - not real-time

$200.80

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Lowe's Companies, Inc. trades at $200.80, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. Over a rolling month the price has lost 5.1%. Relative strength is 37.4 — approaching oversold — and the MACD signal is bearish. Price has been bracketed by support at $199.34 and resistance at $225.79.
Valuation screens as undervalued, on a P/E of 17.0 with no clean sector comparison available. Analyst price targets sit 26.4% above the current price. Revenue is growing at 8.3% on a 7.3% profit margin. The 2.45% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 26.1%, a beta of 0.64 and a maximum drawdown of 30.5%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.

Top Market Events

Lowe’s Companies, Inc. NYSE:LOW delivered an earnings beat alongside weak organic growth and a reduced outlook....Updated Aug 19, 2026 0 — Diluted EPS of $4.Lowe’s Companies, Inc. NYSE:LOW ’s second-quarter results were a mixed bag. The company beat expectations on...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 236.14
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 236.14
  • Analyst targets imply +26.4% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Analyst targets imply +26.4% versus the current price
  • P/E ratio of 17.0
  • Dividend yield of 2.45%

Key Metrics & Analysis

Financial Health

Revenue Growth8.30%
Profit Margin7.35%
P/E Ratio17.0
ROA12.52%
P/B Ratio-15.1
Op. Cash Flow$9.3B
Free Cash Flow$4.6B

Technical Analysis

TrendBearish
RSI37.4
Support$199.34
Resistance$225.79
MA 20$211.36
MA 50$212.90
MA 200$236.14
MACDBearish
VolumeStable
Fear & Greed Index93.36

Valuation

Fair Value$78.46
Target Price$253.76
Upside/Downside26.37%
GradeUndervalued
TypeBlend
Dividend Yield2.45%

Risk Assessment

Beta0.64
Volatility26.12%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.